If you're playing "devil's advocate" it's working well for you. I've invested in several other pharmas that seemed surer bets than ARTH, only to see them go under for various reasons. Other "below-the-radar" bios have hit it big, I used to look at previous posts on those IHub boards after the pop. The risks were high and comments were inaccurate in predicting timing or amount of gains realized.
fine! review what the company has shared! review two or three of the experts on this board--not I...just believe what I have read. and any peer reviews which might come out in one month! only people that really know are the people in the company, and any feedback from experts! these are the people to follow
News 
Market Data 
Discover 
